医院麻醉药品临床合理用药措施对麻醉质量的影响

Objective To investigate the impact of clinical rational drug use interventions measures of narcotic drugs in hospital on anesthesia quality and safety. Methods A retrospective analysis was conducted on 400 anesthesia prescriptions from January to December 2024. Among them, no clinical rational use intervention measures for anesthetic drugs were implemented from January 2024 to June 2024(the first half of the year), which was regarded as the control group, while intervention measures for clinical rational use of anesthetic drugs were implemented from July 2024 to December 2024(the second half of the year), which was regarded as the observation group. Comparative analysis was performed on anesthesia quality, safety, and irrational prescription rates between the two groups. Results The observation group achieved an 87.50%(175/200) excellent anesthesia quality rate, significantly higher than the control group's 68.50%(137/200)(P<0.05). Adverse reactions related to anesthesia drugs occurred in 6.00%(12/200) of the observation group compared to 15.50%(31/200) in the control group, showing statistically significant difference(P<0.05). Irrational prescription rates were 2.00%(4/200) in the observation group versus 8.00%(16/200) in the control group, demonstrating a statistically significant reduction(P<0.05). Conclusion Implementing clinical rational drug use measures for anesthesia medications can enhance anesthesia quality, control adverse reaction risks, and reduce irrational prescription rates.